OCI-AML-20 BioVector NTCC质粒载体菌种细胞基因保藏中心

OCI-AML-20

Cell line name OCI-AML-20
Synonyms OCI-AML20; Ontario Cancer Institute-Acute Myeloid Leukemia-20
Accession CVCL_UE33
Resource Identification Initiative To cite this cell line use: OCI-AML-20 (RRID:CVCL_UE33)
Comments Doubling time: 57 hours (PubMed=30352278).
Omics: Deep RNAseq analysis.
Derived from sampling site: Peripheral blood.
Sequence variations Heterozygous for NRAS p.Gln61Lys (c.181C>A) (ClinVar=VCV000073058) (PubMed=30352278).
Disease Acute myeloid leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2) GATA2, MECOM (NCIt: C82426)
Acute myeloid leukemia with inv3(q21;q26.2) or t(3;3)(q21;q26.2) (ORDO: Orphanet_402020)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling 34Y
Category Cancer cell line
STR profile Source(s): PubMed=30352278

Markers:
Amelogenin X,Y
CSF1PO 11,12
D5S818 11,12
D7S820 8
D13S317 8,11
D16S539 8,12
D21S11 30
TH01 6,9.3
TPOX 10,11
vWA 19,20

Supplier来源:BioVector NTCC Inc.
TEL电话:+86-010-53513060
Website网址: http://www.biovector.net